Switzerland is world famous for its pharmaceutical industry. There are many different pharmaceutical companies all over Switzerland. In the following we present 3 from Basel. All 3 are part of our list of the 100 largest pharmaceutical companies in Switzerland.
- Contains the 100 top-selling pharmaceutical companies from Switzerland from numerous segments such as immunotherapeutics, gynecology, biopharmaceuticals, oncology, OTC drugs, generics, urology, tumor therapy, antibiotics, etc.
- Excellent level of detail: industry and field of activity, sales if publicly available (2020, 2019, 2018, 2017, 2016, 2015), number of employees if publicly available, general contact details, names of executives, etc.
- Free preview available on request via contact [at] researchgermany.de or live chat.
1. F. Hoffmann-La Roche AG: 58.3 billion CHF turnover.
In terms of sales, the Roche Group is considered the largest pharmaceutical company in the world. The company was founded in 1896 by the Basel entrepreneur Fritz Hoffmann-La Roche. The success story started at the end of the 19th century with a popular cough medicine developed in-house. Today, the Roche Group is also active in other fields. The business comprises two areas: Pharmaceuticals and Diagnostics. Pharmaceuticals produces drugs for treatments in cancer, anemia, inflammatory and autoimmune diseases, viral diseases, central nervous system disorders and in a transplant context. The Diagnostics business supplies products for laboratory testing. The Group employs more than 100,000 people. F. Hoffmann-La Roche AG is the operating management company, the legal umbrella of the Group is Roche Holding AG.
2. Novartis AG: 48.7 billion US dollars in sales
The merger of the pharmaceutical and chemical companies Ciba-Geigy and Sandoz in 1996 created a new group with the artificial name Novartis. The roots of the company are much older. Ciba-Geigy’s history dates back to 1758, and Sandoz was founded in 1886. The new group focuses on pharmaceutical products, and the chemicals division was gradually sold. The product portfolio includes a wide range of prescription and over-the-counter medicines. For the generics division, the Sandoz brand was revived in 2003. Sandoz – also based in Basel – forms a Novartis subgroup. Novartis employs more than 100,000 people.
3. Lonza Group AG: CHF 4.5 billion in sales
At the beginning of the Lonza story was an electricity plant in Valais. The electricity generated was used to produce calcium carbide and acetylene. Today, Lonza is active in several chemical and pharmaceutical businesses. There are four business units: Lonza Life Science Ingredients (food and feed additives for agriculture), Lonza Microbial Control (chemicals to control microorganisms), Lonza Custom Manufacturing (ingredients for medicines for various diseases), Lonza Bioscience (auxiliaries for research, development and manufacturing of therapeutic products). The company is headquartered in Basel, and Visp in Valais is an important production site. Lonza has about 14,500 employees.
Picture Source: Unsplash ( Claudio Schwarz, 14.12.21)